New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Black people less likely to receive dementia-related medications

Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,
Neurology June 07,2024
Black people less likely to receive dementia-related medications

Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,
Neurology June 07,2024
Chemist discovers promising compound for a future drug against Alzheimer's disease

Chemist discovers promising compound for a future drug against Alzheimer's disease

by RUDN UniversityCredit: RUDN UniversityBiochemists from RUDN University (Russia) and the University of Bari (Italy) report a group of compounds that can become a molecular scaffold for new drug
Neurology June 07,2024
Chemist discovers promising compound for a future drug against Alzheimer's disease

Chemist discovers promising compound for a future drug against Alzheimer's disease

by RUDN UniversityCredit: RUDN UniversityBiochemists from RUDN University (Russia) and the University of Bari (Italy) report a group of compounds that can become a molecular scaffold for new drug
Neurology June 07,2024
Down syndrome carries raised risk of dementia by 55

Down syndrome carries raised risk of dementia by 55

(HealthDay)—Most people with Down syndrome have dementia by age 55, a new study shows.People with Down syndrome are born with an extra copy of chromosome 21, which often results in developmental disab
Neurology June 07,2024
Down syndrome carries raised risk of dementia by 55

Down syndrome carries raised risk of dementia by 55

(HealthDay)—Most people with Down syndrome have dementia by age 55, a new study shows.People with Down syndrome are born with an extra copy of chromosome 21, which often results in developmental disab
Neurology June 07,2024
Having dementia and reduction in social participation are associated with increased depression and anxiety

Having dementia and reduction in social participation are associated with increased depression and anxiety

by IOS PressMental health and activity participation by dementia status per year of assessment. A) Proportion of depressive symptoms. B) Proportion of anxiety. C) Mean score of social activity. D
Neurology June 07,2024
Having dementia and reduction in social participation are associated with increased depression and anxiety

Having dementia and reduction in social participation are associated with increased depression and anxiety

by IOS PressMental health and activity participation by dementia status per year of assessment. A) Proportion of depressive symptoms. B) Proportion of anxiety. C) Mean score of social activity. D
Neurology June 07,2024
Adults with Alzheimer's risk factors show subtle alterations in brain networks despite normal cognition

Adults with Alzheimer's risk factors show subtle alterations in brain networks despite normal cognition

by Jason Clement,McGill UniversityPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers at McGill University and the Douglas Mental Health University Institute
Neurology June 07,2024
Adults with Alzheimer's risk factors show subtle alterations in brain networks despite normal cognition

Adults with Alzheimer's risk factors show subtle alterations in brain networks despite normal cognition

by Jason Clement,McGill UniversityPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers at McGill University and the Douglas Mental Health University Institute
Neurology June 07,2024
Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer's disease

Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer's disease

by University of WashingtonPET scan of a human brain with Alzheimer's disease. Credit: public domainAlzheimer's is a disease of aggregation. Neurons in the human brain make a protein call
Neurology June 07,2024
Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer's disease

Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer's disease

by University of WashingtonPET scan of a human brain with Alzheimer's disease. Credit: public domainAlzheimer's is a disease of aggregation. Neurons in the human brain make a protein call
Neurology June 07,2024
Dementia rates more than 20% higher among black adults than UK average

Dementia rates more than 20% higher among black adults than UK average

by University College LondonCrude dementia prevalence (95% CI) in those aged 65 and over, by ethnic group. Credit:Alzheimer's & Dementia(2022). DOI: 10.1002/alz.12774Dementia
Neurology June 07,2024
Dementia rates more than 20% higher among black adults than UK average

Dementia rates more than 20% higher among black adults than UK average

by University College LondonCrude dementia prevalence (95% CI) in those aged 65 and over, by ethnic group. Credit:Alzheimer's & Dementia(2022). DOI: 10.1002/alz.12774Dementia
Neurology June 07,2024
Is risk of Alzheimer's linked to specific sleep patterns?

Is risk of Alzheimer's linked to specific sleep patterns?

by American Academy of NeurologyPET scan of a human brain with Alzheimer's disease. Credit: public domainDisturbed sleep patterns do not cause Alzheimer's disease but people who are at hi
Neurology June 07,2024
Is risk of Alzheimer's linked to specific sleep patterns?

Is risk of Alzheimer's linked to specific sleep patterns?

by American Academy of NeurologyPET scan of a human brain with Alzheimer's disease. Credit: public domainDisturbed sleep patterns do not cause Alzheimer's disease but people who are at hi
Neurology June 07,2024
Comorbidities can increase plasma biomarker levels associated with Alzheimer's disease

Comorbidities can increase plasma biomarker levels associated with Alzheimer's disease

by Wake Forest University Baptist Medical CenterCredit: Pixabay/CC0 Public DomainA simple blood test to diagnose Alzheimer's disease, perhaps even years before symptoms appear, is an exciting
Neurology June 07,2024
Comorbidities can increase plasma biomarker levels associated with Alzheimer's disease

Comorbidities can increase plasma biomarker levels associated with Alzheimer's disease

by Wake Forest University Baptist Medical CenterCredit: Pixabay/CC0 Public DomainA simple blood test to diagnose Alzheimer's disease, perhaps even years before symptoms appear, is an exciting
Neurology June 07,2024
How a care program could improve the lives of people with advanced dementia

How a care program could improve the lives of people with advanced dementia

by Lancaster UniversityThe Namaste Care program seeks to give comfort and pleasure to people with advanced dementia through engagement and meaningful activity,. Credit: Lancaster UniversityStaff
Neurology June 07,2024
How a care program could improve the lives of people with advanced dementia

How a care program could improve the lives of people with advanced dementia

by Lancaster UniversityThe Namaste Care program seeks to give comfort and pleasure to people with advanced dementia through engagement and meaningful activity,. Credit: Lancaster UniversityStaff
Neurology June 07,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com